United States· US:50090-3474_50a09a31-9ee0-4cc7-83cd-2d94b32aec33

Letrozole

A letrozole product containing letrozole, registered in United States by A-S Medication Solutions. The same ATC class is registered in 18 of our 19 countries.

ATC L02BG04

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLetrozoleATCL02BG04REGISTER NO.US:50090-3474_50a09a3…PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Letrozole is registered in 18 of 19 countries.

Countries holding a registration under ATC L02BG04 (letrozole), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 11 of them publish a price we can compare per daily dose

Letrozole · ATC L02BG04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of letrozole costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $1.23 in France to $27.12 in United States — a ×22 gap.

  • United States: $27.12 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Letrozole · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • US United States$27.12 (acquisition cost)
  • CH Switzerland$2.73
  • IT Italy$2.51
  • FR France$1.23
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
LETROZOLE
Manufacturer
A-S Medication Solutions
Country
United States (US)
ATC code
L02BG04
ATC class
Letrozole
Defined daily dose
2.5 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    50090-3474-0

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

311 interactions on record for letrozole.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Letrozole · interactions on record

311 records

  • 2 severe
  • 93 moderate
  • 7 minor
  • 209 info

Most severe, free to view

  • ThalidomideL04AX02severe
  • CitalopramN06AB04severe
  • AprepitantA04AD12moderate
  • LonafarnibA16AX20moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Letrozole in 18 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All letrozole products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Femara, Letrofam
  • Belgium · Femara, Letrozol Sandoz
  • Bulgaria · Етрузил, Зеквипра
  • Cyprus · Femara, Feremazol
  • Czechia · Aletro, Dracenax
  • Germany · Femara, Letro-Cell
  • Denmark · Letrozol Accord, Letrozol Medical Valley
  • Estonia · Femara, Feremazol
  • Spain · Femara, Galdar
  • Finland · Femar, Letrolan
  • France · Femara, Letrozole Accord Healthcare
  • United Kingdom (Northern Ireland) · Femara, Letrozole
  • Greece · Femaplex, Femara
  • Croatia · Avomit, Femara
  • Hungary · Etruzil, Famos
  • Ireland · Femara, Letrozole Accord Healthcare Ireland
  • Iceland · Letromal, Letrozol Actavis
  • Italy · Blormat, Brestoral
  • Lithuania · Femara, Feremazol
  • Luxembourg · Femara, Letrozole Eg
  • Latvia · Femara, Letrozole Sanoswiss
  • Malta · Femara, Feremazol
  • Netherlands · Etruzil, Letrostar
  • Norway · Femar, Letrozol Accord
  • Poland · Aromek, Clarzole
  • Portugal · Femara, Letrozol Accord
  • Romania · Elozora, Etruzil
  • Sweden · Letrozol Accord, Letrozol Medical Valley
  • Slovenia · Femara, Letrozol Genthon
  • Slovakia · Aletro, Etruzil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b070a043-c8d5-4a7a-872f-c8c8cd555719
GET /v1/drugs/b070a043-c8d5-4a7a-872f-c8c8cd555719?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "2.5",
  "substance": "LETROZOLE",
  "productndc": "50090-3474",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA090934",
  "marketing_category": "ANDA"
}

See everything about letrozole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.